The primary mechanism of action for 5-HT3 receptor antagonists involves blocking serotonin from binding to its receptors, thereby inhibiting the vomiting reflex. This is particularly important in cancer treatment, as chemotherapy agents can induce the release of serotonin from enterochromaffin cells in the gastrointestinal tract, which then activates the vomiting center in the brain.
